{"product_id":"diagnostic-pathology-kidney-diseases-hardback-9780323661089","title":"Diagnostic Pathology: Kidney Diseases (Hardback) 9780323661089","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eDiagnostic Pathology: Kidney Diseases\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eStay up to date with recent changes in kidney disease pathology\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eRobert B. Colvin (Author), Anthony Chang (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323661089, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 30 April 2019\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1176 pages\u003cbr\u003e27.6 x 21.6 x 5.3 cm, 3.47 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eComprehensive and up to date, the third edition of \u003ci\u003eDiagnostic Pathology: Kidney Diseases, \u003c\/i\u003ewritten by\u003ci\u003e \u003c\/i\u003eRobert B. Colvin, MD and Anthony Chang, MD,\u003ci\u003e \u003c\/i\u003eexpertly covers all aspects of common and rare renal diseases and their variants. This easy-to-use, point-of-care reference offers a state-of-the-art, concise presentation of \u003cb\u003emajor pathological, clinical, pathophysiological, and genetic information for more than 240 diagnoses, \u003c\/b\u003emaking it an ideal resource for pathologists and nephrologists to improve knowledge and skills. \u003cb\u003eSignificantly revised information throughout\u003c\/b\u003e ensures that you remain current with everything new regarding the pathology and pathogenesis of nonneoplastic kidney diseases.\u003c\/p\u003e\n\u003cul\u003e\n\u003cb\u003e \u003cli\u003eNew content with over 20 new chapters\u003c\/li\u003e\u003c\/b\u003e covering idiopathic non-lupus full-house nephropathy, hemophagocytic glomerulonephritis, cryofibrinogenemic glomerulopathy, metabolic syndrome and obesity-related glomerular disease, Whipple disease, systemic Castleman disease, nephropathies due to direct acting antivirals for HCV, checkpoint inhibitors, EGFR antagonists, illicit drugs and opioids, Tums glomerulopathy, vancomycin-induced cast nephropathy, transcript analysis of renal biopsies, new forms of amyloidosis, and mass spectroscopy \u003cli\u003e\n\u003cb\u003eUpdated and validated pathologic classifications systems\u003c\/b\u003e reflect details on new genetic, therapeutic, and pathologic information, including IgA nephropathy, lupus nephritis, vasculitis, and transplant pathology\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eMore than 3,300 outstanding, annotated images\u003c\/b\u003e, including gross and microscopic pathology, a wide range of stains, and detailed medical illustrations, make this an invaluable diagnostic aid for every practicing pathologist, nephrologist, resident, or fellow\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eTime-saving reference features\u003c\/b\u003e include consistently templated chapters, bulleted text, a variety of test data tables, key facts in each chapter, annotated images, and an extensive index\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eInternationally recognized authors\u003c\/b\u003e, many new to this edition, provide fresh perspectives on multiple topics, with a particular emphasis on practical information that directly assists in making and supporting a diagnosis\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eEnhanced eBook version included with purchase\u003c\/b\u003e, which allows you to access all of the text, figures, and references from the book on a variety of devices\u003c\/li\u003e \u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eIntroduction\u003c\/p\u003e    \u003cp\u003eIntroduction and Overview\u003c\/p\u003e  \u003cp\u003eIntroduction to Renal Pathology\u003c\/p\u003e  \u003cp\u003eNormal Kidney Structure\u003c\/p\u003e  \u003cp\u003eNormal Kidney Development\u003c\/p\u003e \u003cp\u003eGlomerular Diseases\u003c\/p\u003e \u003cp\u003ePodocytopathies\u003c\/p\u003e   \u003cp\u003eMinimal Change Disease\u003c\/p\u003e  \u003cp\u003eClassification of FSGS\u003c\/p\u003e  \u003cp\u003eEtiologic Classification of FSGS\u003c\/p\u003e  \u003cp\u003eFSGS, Primary\u003c\/p\u003e  \u003cp\u003eFSGS, Adaptive (Secondary)\u003c\/p\u003e  \u003cp\u003eCollapsing Glomerulopathy\u003c\/p\u003e \u003cp\u003eMembranous Glomerulonephritis\u003c\/p\u003e  \u003cp\u003eEtiologic Classification of Membranous Glomerulonephritis\u003c\/p\u003e  \u003cp\u003eMembranous Glomerulonephritis, Primary\u003c\/p\u003e  \u003cp\u003eMembranous Glomerulonephritis, Secondary\u003c\/p\u003e  \u003cp\u003eMembranous Glomerulonephritis With Anti-TBM Antibodies\u003c\/p\u003e \u003cp\u003eC3-Related Glomerulonephritis and Membranoproliferative Glomerulonephritis\u003c\/p\u003e  \u003cp\u003eClassification of MPGN and Complement-Related Diseases\u003c\/p\u003e  \u003cp\u003eDense Deposit Disease\u003c\/p\u003e  \u003cp\u003eC3 Glomerulonephritis\u003c\/p\u003e  \u003cp\u003eMembranoproliferative Glomerulonephritis With Immune Complexes\u003c\/p\u003e \u003cp\u003eIgA-Related Glomerulonephritis\u003c\/p\u003e  \u003cp\u003eOverview of IgA-Related Glomerulopathies\u003c\/p\u003e  \u003cp\u003eIgA Nephropathy\u003c\/p\u003e  \u003cp\u003eIgA Vasculitis (Henoch-Schönlein Purpura)\u003c\/p\u003e \u003cp\u003eSLE and Related Autoantibody-Mediated GN\u003c\/p\u003e  \u003cp\u003eSystemic Lupus Erythematosus\u003c\/p\u003e  \u003cp\u003eMixed Connective Tissue Disease\u003c\/p\u003e  \u003cp\u003eRheumatoid Arthritis\u003c\/p\u003e  \u003cp\u003eMixed Cryoglobulinemic Glomerulonephritis\u003c\/p\u003e  \u003cp\u003eIdiopathic Nonlupus Full-House Nephropathy\u003c\/p\u003e \u003cp\u003eAnti-GBM Nephritis\u003c\/p\u003e  \u003cp\u003eAnti-GBM Glomerulonephritis\u003c\/p\u003e  \u003cp\u003eAtypical Anti-GBM Nephritis\u003c\/p\u003e \u003cp\u003eMonoclonal Immunoglobulin Diseases\u003c\/p\u003e  \u003cp\u003eIntroduction to Diseases With Monoclonal Immunoglobulin Deposits\u003c\/p\u003e  \u003cp\u003eMonoclonal Immunoglobulin Deposition Disease\u003c\/p\u003e  \u003cp\u003eProliferative Glomerulonephritis With Monoclonal IgG Deposits\u003c\/p\u003e  \u003cp\u003eMembranous Glomerulonephritis With Masked IgG ? Deposits\u003c\/p\u003e  \u003cp\u003eType I Cryoglobulinemic Glomerulonephritis\u003c\/p\u003e  \u003cp\u003eWaldenström Macroglobulinemia\u003c\/p\u003e \u003cp\u003eAmyloidosis\u003c\/p\u003e    \u003cp\u003eAmyloidosis Classification\u003c\/p\u003e  \u003cp\u003eAL\/AH Amyloidosis\u003c\/p\u003e  \u003cp\u003eAA Amyloidosis\u003c\/p\u003e  \u003cp\u003eAFib Amyloidosis\u003c\/p\u003e  \u003cp\u003eAGel Amyloidosis\u003c\/p\u003e  \u003cp\u003eALECT2 Amyloidosis\u003c\/p\u003e  \u003cp\u003eAApoAI Amyloidosis\u003c\/p\u003e  \u003cp\u003eApoAII Amyloidosis\u003c\/p\u003e  \u003cp\u003eAApoAIV Amyloidosis\u003c\/p\u003e  \u003cp\u003eAApoCII Amyloidosis\u003c\/p\u003e  \u003cp\u003eATTR Amyloidosis\u003c\/p\u003e \u003cp\u003eIdiopathic Fibrillary Glomerulopathies\u003c\/p\u003e  \u003cp\u003eDiseases With Organized Deposits\u003c\/p\u003e  \u003cp\u003eFibrillary Glomerulopathy\u003c\/p\u003e  \u003cp\u003eImmunotactoid Glomerulopathy\u003c\/p\u003e  \u003cp\u003eFibronectin Glomerulopathy\u003c\/p\u003e \u003cp\u003eDiabetic Renal Disease\u003c\/p\u003e  \u003cp\u003eDiabetic Nephropathy\u003c\/p\u003e  \u003cp\u003eIdiopathic Nodular Glomerulopathy\u003c\/p\u003e \u003cp\u003eInfection-Related Glomerular Disease\u003c\/p\u003e  \u003cp\u003eOverview of Infection-Related Glomerular Disease\u003c\/p\u003e  \u003cp\u003eAcute Poststreptococcal Glomerulonephritis\u003c\/p\u003e  \u003cp\u003eAcute Postinfectious Glomerulonephritis, Nonstreptococcal\u003c\/p\u003e  \u003cp\u003eIgA Acute Glomerulonephritis Associated With *Staphylococcus aureus*\u003c\/p\u003e  \u003cp\u003eGlomerulonephritis of Chronic Infection, Including Shunt Nephritis\u003c\/p\u003e  \u003cp\u003eEndocarditis\u003c\/p\u003e   \u003cp\u003eSyphilis\u003c\/p\u003e    \u003cp\u003eLyme Disease\u003c\/p\u003e  \u003cp\u003eHepatitis B Virus\u003c\/p\u003e  \u003cp\u003eHepatitis C Virus\u003c\/p\u003e  \u003cp\u003eHIV-Associated Nephropathy\u003c\/p\u003e  \u003cp\u003eMiscellaneous HIV-Associated Renal Diseases\u003c\/p\u003e  \u003cp\u003eSchistosomiasis\u003c\/p\u003e  \u003cp\u003eFilariasis\u003c\/p\u003e    \u003cp\u003eLeishmaniasis\u003c\/p\u003e \u003cp\u003eDrug Induced Glomerular Diseases\u003c\/p\u003e  \u003cp\u003eDrug-Induced Minimal Change Disease\u003c\/p\u003e  \u003cp\u003eBisphosphonate-Induced Collapsing Glomerulopathy\u003c\/p\u003e  \u003cp\u003eChloroquine Toxicity\u003c\/p\u003e  \u003cp\u003eAnti-Hepatitis C Virus Drugs\u003c\/p\u003e  \u003cp\u003eAnti-EGFR Drugs\u003c\/p\u003e \u003cp\u003eGenetic Diseases of the Glomerulus\u003c\/p\u003e  \u003cp\u003eOverview and Classification of Genetic Diseases of the Glomerulus\u003c\/p\u003e \u003cp\u003eGenetic Diseases of the Glomerular Basement Membrane Collagen\u003c\/p\u003e  \u003cp\u003eAlport Syndrome\u003c\/p\u003e  \u003cp\u003eThin Basement Membrane Disease\u003c\/p\u003e \u003cp\u003eGenetic Diseases of the Podocyte\u003c\/p\u003e  \u003cp\u003eDiffuse Mesangial Sclerosis\u003c\/p\u003e  \u003cp\u003eCongenital Nephrotic Syndrome of the Finnish Type\u003c\/p\u003e  \u003cp\u003ePierson Syndrome\u003c\/p\u003e  \u003cp\u003eGalloway-Mowat Syndrome\u003c\/p\u003e  \u003cp\u003eDenys-Drash Syndrome\u003c\/p\u003e  \u003cp\u003eFrasier Syndrome\u003c\/p\u003e  \u003cp\u003ePodocin Deficiency\u003c\/p\u003e  \u003cp\u003eAlpha-Actinin-4 Deficiency\u003c\/p\u003e  \u003cp\u003eAutosomal Dominant FSGS Due to *INF2* Mutations\u003c\/p\u003e  \u003cp\u003e*APOL1*-Related Glomerular Disease\u003c\/p\u003e  \u003cp\u003eSchimke Immuno-Osseous Dysplasia\u003c\/p\u003e \u003cp\u003eGenetic Storage and Lipid Diseases\u003c\/p\u003e  \u003cp\u003eLecithin-Cholesterol Acyltransferase Deficiency\u003c\/p\u003e  \u003cp\u003eAPOE Lipoprotein Glomerulopathy\u003c\/p\u003e  \u003cp\u003eType III Hyperlipoproteinemia\u003c\/p\u003e  \u003cp\u003eFabry Disease\u003c\/p\u003e  \u003cp\u003eGaucher Glomerulopathy\u003c\/p\u003e  \u003cp\u003eI-Cell Disease (Mucolipidosis II)\u003c\/p\u003e  \u003cp\u003eAlagille Syndrome\u003c\/p\u003e \u003cp\u003eOther Genetic Diseases Affecting the Glomerulus\u003c\/p\u003e  \u003cp\u003eGlomerulopathy of Hereditary Multiple Exostoses\u003c\/p\u003e  \u003cp\u003eType III Collagen Glomerulopathy\u003c\/p\u003e  \u003cp\u003eNail-Patella Syndrome\u003c\/p\u003e \u003cp\u003eMiscellaneous Glomerular Diseases\u003c\/p\u003e  \u003cp\u003eC1q Nephropathy\u003c\/p\u003e  \u003cp\u003eIgM Nephropathy\u003c\/p\u003e  \u003cp\u003eCryofibrinogenic Glomerulopathy\u003c\/p\u003e  \u003cp\u003eHepatic Glomerulosclerosis and IgA Deposition\u003c\/p\u003e  \u003cp\u003eHemophagocytic Glomerulopathy\u003c\/p\u003e  \u003cp\u003ePodocyte Infolding Glomerulopathy\u003c\/p\u003e  \u003cp\u003eMetabolic Syndrome\/Obesity-Related Glomerular Disease\u003c\/p\u003e  \u003cp\u003eIntravascular Large B-Cell Lymphoma\u003c\/p\u003e \u003cp\u003eVascular Diseases\u003c\/p\u003e  \u003cp\u003eOverview and Classification of Systemic Vasculitides\u003c\/p\u003e \u003cp\u003eANCA Disease\u003c\/p\u003e   \u003cp\u003eANCA-Related Glomerulonephritis\u003c\/p\u003e  \u003cp\u003eMicroscopic Polyangiitis\u003c\/p\u003e  \u003cp\u003eGranulomatosis With Polyangiitis\u003c\/p\u003e  \u003cp\u003eEosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)\u003c\/p\u003e  \u003cp\u003eDrug-Induced ANCA Vasculitis\u003c\/p\u003e \u003cp\u003eNon-ANCA Vasculitides\u003c\/p\u003e  \u003cp\u003ePolyarteritis Nodosa\u003c\/p\u003e  \u003cp\u003eKawasaki Disease\u003c\/p\u003e  \u003cp\u003eGiant Cell Arteritis\u003c\/p\u003e  \u003cp\u003eTakayasu Arteritis\u003c\/p\u003e  \u003cp\u003eHypocomplementemic Urticarial Vasculitis (Anti-C1q Vasculitis)\u003c\/p\u003e \u003cp\u003eThrombotic Microangiopathies\u003c\/p\u003e  \u003cp\u003eIntroduction to Thrombotic Microangiopathies\u003c\/p\u003e  \u003cp\u003eHemolytic Uremic Syndrome, Infection Related\u003c\/p\u003e  \u003cp\u003eThrombotic Microangiopathy, Genetic\u003c\/p\u003e  \u003cp\u003eThrombotic Microangiopathy, Autoimmune\u003c\/p\u003e  \u003cp\u003eThrombotic Microangiopathy, Drug Induced\u003c\/p\u003e  \u003cp\u003ePostpartum Hemolytic Uremic Syndrome\u003c\/p\u003e  \u003cp\u003eScleroderma Renal Disease\u003c\/p\u003e  \u003cp\u003eMulticentric Castleman Disease\u003c\/p\u003e \u003cp\u003eOther Diseases Affecting the Endothelium\u003c\/p\u003e  \u003cp\u003ePreeclampsia, Eclampsia, HELLP Syndrome\u003c\/p\u003e  \u003cp\u003eRadiation Nephropathy\u003c\/p\u003e  \u003cp\u003eGlomerulopathy of Hereditary Multiple Extoses\u003c\/p\u003e  \u003cp\u003eSickle Cell Nephropathy\u003c\/p\u003e \u003cp\u003eHypertensive Renal Disease\u003c\/p\u003e  \u003cp\u003eHypertensive Renovascular Disease\u003c\/p\u003e  \u003cp\u003eRenal Artery Stenosis\u003c\/p\u003e  \u003cp\u003eFibromuscular Dysplasia\u003c\/p\u003e  \u003cp\u003eNeurofibromatosis\u003c\/p\u003e \u003cp\u003eThrombotic and Embolic Disease\u003c\/p\u003e  \u003cp\u003eRenal Vein Thrombosis\u003c\/p\u003e  \u003cp\u003eRenal Artery Thrombosis\u003c\/p\u003e  \u003cp\u003eAtheromatous Emboli\u003c\/p\u003e  \u003cp\u003eHydrophilic Polymer Emboli\u003c\/p\u003e \u003cp\u003eTubulointerstitial Diseases\u003c\/p\u003e \u003cp\u003eOverview and Classification of Tubulointerstitial Diseases\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis of Acute Interstitial Nephritis\u003c\/p\u003e \u003cp\u003eIschemic Injury\u003c\/p\u003e   \u003cp\u003eAcute Tubular Injury\u003c\/p\u003e  \u003cp\u003eRenal Cortical Necrosis\u003c\/p\u003e  \u003cp\u003eSepticemia\/Shock\u003c\/p\u003e  \u003cp\u003eBile Cast Nephropathy\u003c\/p\u003e \u003cp\u003eImmunologic Tubular Disease\u003c\/p\u003e  \u003cp\u003eTubulointerstitial Nephritis With Uveitis\u003c\/p\u003e  \u003cp\u003eSjögren Syndrome\u003c\/p\u003e  \u003cp\u003eIgG4-Related Kidney Disease\u003c\/p\u003e  \u003cp\u003eIdiopathic Hypocomplementemic Tubulointerstitial Nephritis\u003c\/p\u003e  \u003cp\u003eAnti-Tubular Basement Membrane Disease\u003c\/p\u003e  \u003cp\u003eAntibrush Border Autoantibody Tubulointerstitial Nephritis\u003c\/p\u003e  \u003cp\u003eSarcoidosis\u003c\/p\u003e   \u003cp\u003eTubulointerstiital Nephritis with IgM+ Plasma Cells\u003c\/p\u003e  \u003cp\u003eGiant Cell Tubulitis With TBM Deposits\u003c\/p\u003e \u003cp\u003eMonoclonal Immunoglobulin Diseases of Tubules\u003c\/p\u003e  \u003cp\u003eLight Chain Cast Nephropathy\u003c\/p\u003e  \u003cp\u003eLight Chain Proximal Tubulopathy With Crystals\u003c\/p\u003e  \u003cp\u003eLight Chain Proximal Tubulopathy Without Crystals\u003c\/p\u003e \u003cp\u003eDrug-Induced Tubulointerstitial Diseases\u003c\/p\u003e  \u003cp\u003eDrug-Induced Acute Interstitial Nephritis\u003c\/p\u003e  \u003cp\u003eDrugs That Cause Tubulointerstitial Nephritis\u003c\/p\u003e  \u003cp\u003eCheckpoint Inhibitor-Induced Kidney Diseases\u003c\/p\u003e  \u003cp\u003ePapillary Necrosis\u003c\/p\u003e  \u003cp\u003eMyoglobinuria\/Rhabdomyolysis\/Hemoglobinuria\u003c\/p\u003e  \u003cp\u003eCisplatin Nephrotoxicity\u003c\/p\u003e  \u003cp\u003eOsmotic Tubulopathy\u003c\/p\u003e  \u003cp\u003eAntiviral Drug Nephrotoxicity\u003c\/p\u003e  \u003cp\u003eAcute Phosphate Nephropathy\u003c\/p\u003e  \u003cp\u003eLithium-Induced Renal Disease\u003c\/p\u003e  \u003cp\u003eCalcineurin Inhibitor Toxicity\u003c\/p\u003e  \u003cp\u003emTOR Inhibitor Toxicity\u003c\/p\u003e  \u003cp\u003eVancomycin-Induced Cast Nephropathy\u003c\/p\u003e  \u003cp\u003eWarfarin Nephropathy\u003c\/p\u003e  \u003cp\u003eIllicit Drugs and Opioids\u003c\/p\u003e \u003cp\u003eToxic Injury\u003c\/p\u003e    \u003cp\u003eLead and Other Heavy Metal Toxins\u003c\/p\u003e  \u003cp\u003eAristolochic Acid Nephropathy\u003c\/p\u003e  \u003cp\u003eBalkan Endemic Nephropathy\u003c\/p\u003e  \u003cp\u003eEthylene Glycol Toxicity\u003c\/p\u003e  \u003cp\u003eArgyria\u003c\/p\u003e   \u003cp\u003eAutosomal Dominant Tubulointerstitial Kidney Disease\u003c\/p\u003e  \u003cp\u003eAutosomal Dominant Tubulointerstitial Kidney Disease, *MUC1*-Related\u003c\/p\u003e  \u003cp\u003eAutosomal Dominant Tubulointerstitial Kidney Disease, *UMOD*-Related\u003c\/p\u003e  \u003cp\u003eAutosomal Dominant Tubulointerstitial Kidney Disease, *REN*-Related\u003c\/p\u003e  \u003cp\u003eAutosomal Dominant Tubulointerstitial Kidney Disease, *HNF1B*-Related\u003c\/p\u003e \u003cp\u003eGenetic Crystal Depostion Diseases\u003c\/p\u003e  \u003cp\u003ePrimary Hyperoxaluria\u003c\/p\u003e  \u003cp\u003e2,8-Dihydroxyadeninuria\u003c\/p\u003e  \u003cp\u003eCystinosis\u003c\/p\u003e   \u003cp\u003eUric Acid Nephropathy\/Gout\u003c\/p\u003e \u003cp\u003eGenetic Transport Diseases\u003c\/p\u003e  \u003cp\u003eBartter Syndrome\u003c\/p\u003e  \u003cp\u003eDent Disease\u003c\/p\u003e  \u003cp\u003eOculocerebrorenal Syndrome of Lowe\u003c\/p\u003e \u003cp\u003eOther Genetic Diseases Affecting Tubules\u003c\/p\u003e  \u003cp\u003eMethylmalonic Acidemia\u003c\/p\u003e  \u003cp\u003eSystemic Karyomegaly\u003c\/p\u003e  \u003cp\u003eMitochondriopathies\u003c\/p\u003e \u003cp\u003eMiscellaneous Tubulointerstitial Diseases\u003c\/p\u003e  \u003cp\u003eNephrocalcinosis\u003c\/p\u003e  \u003cp\u003eSecondary Oxalosis\u003c\/p\u003e  \u003cp\u003eMesoamerican Nephropathy\u003c\/p\u003e  \u003cp\u003eExtramedullary Hematopoiesis\u003c\/p\u003e \u003cp\u003eInfections of the Kidney\u003c\/p\u003e \u003cp\u003eBacterial Infections of the Kidney\u003c\/p\u003e  \u003cp\u003eAcute Pyelonephritis\u003c\/p\u003e  \u003cp\u003eChronic Pyelonephritis\u003c\/p\u003e  \u003cp\u003eXanthogranulomatous Pyelonephritis\u003c\/p\u003e  \u003cp\u003eMalakoplakia\u003c\/p\u003e  \u003cp\u003eTuberculosis\u003c\/p\u003e   \u003cp\u003eBCG Granulomatous Interstitial Nephritis\u003c\/p\u003e  \u003cp\u003eLeprosy\u003c\/p\u003e    \u003cp\u003eMegalocytic Interstitial Nephritis\u003c\/p\u003e  \u003cp\u003eNocardiosis\u003c\/p\u003e   \u003cp\u003eLeptospirosis\u003c\/p\u003e  \u003cp\u003eWhipple Disease\u003c\/p\u003e \u003cp\u003eFungal, Rickettsial, and Parasitic Infections of the Kidney\u003c\/p\u003e  \u003cp\u003eMucormycosis\u003c\/p\u003e  \u003cp\u003eCandidiasis\u003c\/p\u003e   \u003cp\u003eHistoplasmosis\u003c\/p\u003e  \u003cp\u003eCoccidioidomycosis\u003c\/p\u003e  \u003cp\u003eBlastomycosis\u003c\/p\u003e  \u003cp\u003eParacoccidioidomycosis\u003c\/p\u003e  \u003cp\u003eAspergillosis\u003c\/p\u003e  \u003cp\u003eCryptococcosis\u003c\/p\u003e  \u003cp\u003eMicrosporidiosis\u003c\/p\u003e  \u003cp\u003eRickettsial Infections\u003c\/p\u003e  \u003cp\u003eToxoplasmosis\u003c\/p\u003e  \u003cp\u003eHydatidosis\u003c\/p\u003e  \u003cp\u003eViral Infections of the Kidney\u003c\/p\u003e  \u003cp\u003ePolyomavirus Nephritis\u003c\/p\u003e  \u003cp\u003eCytomegalovirus Infection\u003c\/p\u003e  \u003cp\u003eAdenovirus Infection\u003c\/p\u003e  \u003cp\u003eEpstein-Barr Virus Nephritis\u003c\/p\u003e  \u003cp\u003eHerpes Simplex Acute Nephritis\u003c\/p\u003e  \u003cp\u003eHantavirus Nephropathy\u003c\/p\u003e \u003cp\u003eDevelopmental Diseases\u003c\/p\u003e \u003cp\u003eOverview of Congenital Anomalies of the Kidney and Urinary Tract\u003c\/p\u003e \u003cp\u003eDysplasia\/Hypoplasia\/Agenesis\u003c\/p\u003e \u003cp\u003eOligomeganephronia\u003c\/p\u003e \u003cp\u003eEctopia, Malrotation, Duplication, Fusion, Supernumerary Kidney\u003c\/p\u003e \u003cp\u003eAsk-Upmark Kidney\u003c\/p\u003e \u003cp\u003eRenal Tubular Dysgenesis\u003c\/p\u003e \u003cp\u003eCystic Diseases\u003c\/p\u003e   \u003cp\u003eOverview of Cystic Diseases\u003c\/p\u003e \u003cp\u003eCiliopathies\u003c\/p\u003e    \u003cp\u003eAutosomal Dominant Polycystic Kidney Disease\u003c\/p\u003e  \u003cp\u003eAutosomal Recessive Polycystic Kidney Disease\u003c\/p\u003e  \u003cp\u003eNephronophthisis and Related Ciliopathies\u003c\/p\u003e \u003cp\u003eOther Genetic Cystic Diseases\u003c\/p\u003e  \u003cp\u003evon Hippel-Lindau Disease\u003c\/p\u003e  \u003cp\u003eTuberous Sclerosis Complex\u003c\/p\u003e  \u003cp\u003eZellweger Syndrome\u003c\/p\u003e \u003cp\u003eMiscellaneous Cystic Diseases\u003c\/p\u003e  \u003cp\u003eMedullary Sponge Kidney\u003c\/p\u003e  \u003cp\u003eMixed Epithelial and Stromal Tumor Family\u003c\/p\u003e  \u003cp\u003ePediatric Cystic Nephroma\u003c\/p\u003e  \u003cp\u003eAcquired Cystic Disease\u003c\/p\u003e  \u003cp\u003eSimple and Miscellaneous Cysts\u003c\/p\u003e  \u003cp\u003eRenal Lymphangioma\/Lymphangiectasia\u003c\/p\u003e \u003cp\u003eDiseases of the Collecting System\u003c\/p\u003e \u003cp\u003eIntroduction to Impediments to Urine Flow\u003c\/p\u003e \u003cp\u003eReflux Nephropathy\u003c\/p\u003e \u003cp\u003eObstructive Nephropathy\u003c\/p\u003e \u003cp\u003eNephrolithiasis\u003c\/p\u003e  \u003cp\u003eLoin Pain Hematuria Syndrome\u003c\/p\u003e \u003cp\u003eDiseases of the Renal Allograft\u003c\/p\u003e \u003cp\u003ePathologic Classification of Renal Allograft Diseases\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e    \u003cp\u003eEvaluation of Allograft Kidney\u003c\/p\u003e  \u003cp\u003eEvaluation of the Donor Kidney\u003c\/p\u003e \u003cp\u003eRejection\u003c\/p\u003e     \u003cp\u003eAcute T-Cell-Mediated Rejection\u003c\/p\u003e  \u003cp\u003eChronic T-Cell-Mediated Rejection\u003c\/p\u003e  \u003cp\u003eHyperacute Rejection\u003c\/p\u003e  \u003cp\u003eAcute Antibody-Mediated Rejection\u003c\/p\u003e  \u003cp\u003eChronic Antibody-Mediated Rejection\u003c\/p\u003e  \u003cp\u003eTranscript Analysis of Renal Transplant Biopsies\u003c\/p\u003e \u003cp\u003eRecurrent and De Novo Diseases\u003c\/p\u003e  \u003cp\u003eDiseases That Recur in Allografts\u003c\/p\u003e  \u003cp\u003eDe Novo FSGS\u003c\/p\u003e  \u003cp\u003eDe Novo Membranous Glomerulonephritis\u003c\/p\u003e  \u003cp\u003eAnti-GBM Disease in Alport Syndrome\u003c\/p\u003e  \u003cp\u003eEngraftment Syndrome\u003c\/p\u003e \u003cp\u003eNonimmunologic Injury\u003c\/p\u003e  \u003cp\u003eAcute Allograft Ischemia\u003c\/p\u003e  \u003cp\u003eHyperperfusion Injury\u003c\/p\u003e  \u003cp\u003eUrine Leak\u003c\/p\u003e   \u003cp\u003eLymphocele\u003c\/p\u003e   \u003cp\u003eTransplant Renal Artery Stenosis\u003c\/p\u003e  \u003cp\u003eRenal Artery or Vein Thrombosis\u003c\/p\u003e  \u003cp\u003ePosttransplant Lymphoproliferative Disease\u003c\/p\u003e  \u003cp\u003eBK Polyomavirus Neoplasia\u003c\/p\u003e \u003cp\u003eStable and Accepted Grafts\u003c\/p\u003e  \u003cp\u003eProtocol Biopsies\u003c\/p\u003e  \u003cp\u003eAccommodation\u003c\/p\u003e  \u003cp\u003eTolerance\u003c\/p\u003e  \u003cp\u003eKidney Pathology in Recipients of Other Transplants \u003c\/p\u003e  \u003cp\u003eKidney Diseases in Nonrenal Transplant Recipients\u003c\/p\u003e  \u003cp\u003eGraft-vs.-Host Glomerulopathies\u003c\/p\u003e \u003cp\u003eProtocols\u003c\/p\u003e     \u003cp\u003eBiopsy Reports\u003c\/p\u003e  \u003cp\u003eKidney Needle Biopsy: Evaluation for Adequacy\u003c\/p\u003e \u003cp\u003eEvaluation of Fibrosis\u003c\/p\u003e \u003cp\u003eImmunofluorescence on Paraffin Tissue Sections\u003c\/p\u003e \u003cp\u003eEM Processing From Paraffin or Frozen Tissue\u003c\/p\u003e \u003cp\u003eDetection of PLA2R Deposits and Autoantibodies\u003c\/p\u003e \u003cp\u003eAlport Collagen IV Immunofluorescence\u003c\/p\u003e \u003cp\u003eC4d Immunohistochemistry\/Immunofluorescence\u003c\/p\u003e \u003cp\u003ePolyomavirus Detection in Tissue\u003c\/p\u003e \u003cp\u003eMass Spectrometry\u003c\/p\u003e \u003cp\u003eDiagnostic Genetics of Kidney Diseases\u003c\/p\u003e \u003cp\u003eExamination of the End-Stage Kidney\u003c\/p\u003e \u003cp\u003eExamination of Tumor Nephrectomy Specimens for Nonneoplastic Diseases\u003c\/p\u003e \u003cp\u003eEvaluation of the Transplant Nephrectomy\u003c\/p\u003e \u003cp\u003eEvaluation of Autopsy Kidneys\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Pathology [\u003ca title=\"See our other books on Pathology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Pathology%20%5BMMF%5D%22\"\u003eMMF\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648336875800,"sku":"9780323661089","price":205.69,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323661089_550b9968-bf6a-43c9-84ec-dbb6fa89f6d5.jpg?v=1694990033","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/diagnostic-pathology-kidney-diseases-hardback-9780323661089","provider":"Freshly Printed Books","version":"1.0","type":"link"}